Vincerx Pharma, Inc. - Common Stock (VINC)

CUSIP: 92731L106

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock
Total 13F shares
10,703,397
Share change
-1,367,808
Total reported value
$10,822,316
Price per share
$1.01
Number of holders
35
Value change
-$1,891,253
Number of buys
11
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 92731L106?
CUSIP 92731L106 identifies VINC - Vincerx Pharma, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q3 2023

As of 30 Sep 2023, Vincerx Pharma, Inc. - Common Stock (VINC) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,703,397 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, SAGE RHINO CAPITAL LLC, BANK OF AMERICA CORP /DE/, Long Focus Capital Management, LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, ExodusPoint Capital Management, LP, KINGDON CAPITAL MANAGEMENT, L.L.C., Rubric Capital Management LP, and Point72 Asset Management, L.P.. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.